Changmao Bio Schedules 18 Aug 2026 Board Meeting to Approve 1H26 Interim Results and Dividend Proposal

Bulletin Express
08/03

Changmao Biochemical Engineering Company Limited (Changmao Bio) has announced that its board of directors will convene on 18 August 2026 at 3:00 p.m. in the People’s Republic of China.

The agenda includes: 1. Approval of the unaudited interim results for the six months ended 30 June 2026 and endorsement of the corresponding results announcement for publication on the Hong Kong Stock Exchange website. 2. Consideration of an interim dividend payout, if any. 3. Review of any necessary closure period for the Register of Members. 4. Discussion of other routine corporate matters.

The meeting notice was signed by Chairman Rui Xin Sheng on 3 August 2026. As of the announcement date, the board comprises three executive directors, three non-executive directors and three independent non-executive directors.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10